Diabetes and cardiac disease in South Asians

British Journal of Diabetes and Vascular Disease

Volumn 5, Issue 5, 2005, Pages 253-259

  Mukhopadhyay, Babulayeb ^a,c   Sattar, Naveed ^b   Fisher, Miles ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c HAIRMYRES HOSPITAL   (United Kingdom)

Author keywords

Cardiovascular risk; Diabetes; South Asians

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADIPONECTIN; FOLIC ACID; GLICLAZIDE; GLUCOSE; HOMOCYSTEINE; INSULIN; INSULIN GLARGINE; LIPOPROTEIN A; NATEGLINIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; RAMIPRIL; ROSIGLITAZONE; SULFONYLUREA DERIVATIVE; VALSARTAN;

AMINO ACID BLOOD LEVEL; ASIAN; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUCASIAN; CLINICAL TRIAL; DIABETES CONTROL; DIETARY INTAKE; DISEASE PREDISPOSITION; GLUCOSE BLOOD LEVEL; HEALTH BEHAVIOR; HEART DEATH; HEREDITY; HIGH RISK POPULATION; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERLIPIDEMIA; HYPERTENSION; IMMIGRATION; INFLAMMATION; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LIFESTYLE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; PREVALENCE; PROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SOCIAL ASPECT; SOUTH ASIA; THROMBOGENICITY; WEIGHT GAIN;

EID: 28444477420     PISSN: 14746514     EISSN: None     Source Type: Journal    
DOI: 10.1177/14746514050050050301     Document Type: Review

References (55)

1. Mather H, Keen H. The Southall Diabetes survey: prevalence of known diabetes in Asians and Europeans. BMJ (Clin Res Ed) 1985;291:1081-4.
2. Samanta A, Burden AC, Fent B. Comparative prevalence of non-insulin dependant diabetes mellitus in Asian and white Caucasian adults. Diabetes Res Clin Pract 1987;4:1-6.
3. Ramachandran A, Snehalata C, Kapur A et al. High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia 2001;44:1094-101.
4. Gupta R, Gupta VP. Meta-analysis of coronary heart disease prevalence in India. Indian Heart J 1996;48:241-5.
5. Wild S, McKeigue P. Cross-sectional analysis of mortality by country of birth in England and Wales, 1970-92. BMJ 1997;314:705-10.
6. Sheth T, Nair C, Nargundkar M, Anand S, Yusuf S. Cardiovascular and cancer mortality among Canadians of European, south Asian and Chinese origin from 1979 to 1993: an analysis of 1.2 million deaths. CMAJ 1999;161:132-8.
7. McKeigue PM, Ferrie JE, Marmot MG. Association of early-onset Coronary Heart Disease in south Asian men with glucose intolerance and hyperinsulinaemia. Circulation 1993;87:152-61.
8. Mather HM, Chaturvedi N, Fuller JH. Mortality and morbidity from diabetes in south Asians and Europeans: 11-year follow-up of the Southall Diabetes Survey, London, UK. Diabet Med 1998;15:53-9.
9. UK Prospective Diabetes Study Group. The incidence of myocardial infarction in White, south Asian and Afro-Caribbean patients with type 2 diabetes (UKPDS 32). Diabetes Care 1998;21:1271-7.
10. Davis TME, Cull CA, Holman RR for the UKPDS group. Relationship between ethnicity and glycaemic control, lipid profiles and blood pressure during the first 9 years of type 2 diabetes. Diabetes Care 2001; 24:1167-74.
11. UK Prospective Diabetes Study Group. UK Prospective Diabetes Study XII: Differences between Asian, AfroCaribbean and White Caucasian type 2 diabetic patients at diagnosis of diabetes. Diabet Med 1994;11:670-7.
12. Wilkinson P, Sayer J, Koorithottumkal L et al. Comparison of case fatality in south Asian and white patients after acute myocardial infarction: observational study. BMJ 1996;312:1330-3.
13. Bhopal R, Unwin N, White M et al. Heterogeneity of coronary heart disease risk factors in Indian, Pakistani, Bangladeshi and European origin populations: cross sectional study. BMJ 1999;319:215-20.
14. Yusuf S, Hawken S, Ounpuu S, Dans T et al. on behalf of INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-52.
15. Sniderman AD, Furberg CD, Keech A et al. Apoproteins versus lipids as indices of coronary risk and as targets for statin therapy: analysis of the evidence. Lancet 2003;36:777-80.
16. Williams K, Sniderman AD, Sattar N, D'Agostino R Jr, Wagenknecht LE, Haffner SM. Comparison of the associations of apolipoprotein B and low-density lipoprotein cholesterol with other cardiovascular risk factors in the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2003;108:2312-16.
17. Bhatnagar D, Anand IS, Durrington PN et al. Coronary risk factors in people from the Indian subcontinent living in west London and their siblings in India. Lancet 1995;345:405-09.
18. McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in south Asians. Lancet 1991;337:382-6.
19. Pan CY, So WY, Khalid BAK et al. on behalf of the ASDIAB Study Group. Metabolic, immunological and clinical characteristics in newly diagnosed Asian diabetes patients aged 12-40 years. Diabet Med 2004;21:1007-13.
20. Whincup PH, Gilg JA, Papacosta O et al. Early evidence of ethnic differences in cardiovascular risk: cross sectional comparison of British South Asian and white children. BMJ 2002;324:635-8.
21. Yajnik CS, Lubree HG, Rege SS et al. Adiposity and hyperinsulinaemia in Indians are present at birth. J Clin Endocrinol Metab 2002;87:5575-80.
22. Lydakis C, Lip G. Microalbuminuria and cardiovascular risk. QJM 1998;91: 381-91.
23. Fischbacher CM, Bhopal R, Rutter MK et al. Microalbuminuria is more frequent in south Asian than in European origin populations: a comparative study in Newcastle UK. Diabet Med 2003;20:31-6.
24. Anand SS, Yusuf S, Vuksan V et al. for the SHARE investigators. Differences in risk factors, atherosclerosis and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups. Lancet 2000;356:279-84.
25. Festa A, D'gostino R Jr, Tracy RP, Haffner SM. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 2002;51:1131-7.
26. Kain K, Catto AJ, Grant PJ. Impaired fibrinolysis and increased fibrinogen levels in south Asian subjects. Atherosclerosis 2001;156:457-61.
27. Kain K, Catto AJ, Grant PJ. Associations between insulin resistance and thrombotic risk factors in high-risk south Asian subjects. Diabet Med 2003;20:651-5.
28. Forouhi NG, Rumley A, Lowe GD, McKeigue P, Sattar N. Specific elevation in plasma tissue plasminogen activator antigen concentrations in South Asians relative to Europeans. Blood Coagul Fibrinolysis 2003;14: 755-60.
29. Eliasson MC, Jansson JH, Lindahl B, Stegmayr B. High levels of tissue plasminogen activator (tPA) antigen precede the development of type 2 diabetes in a longitudinal population study. The Northern Sweden MONICA Study. Cardiovasc Diabetol 2003;2:19.
30. Lowe GD, Danesh J, Lewington S et al. Tissue plasminogen activator antigen and coronary heart disease. Prospective study and meta-analysis. Eur Heart J 2004;25:252-9.
31. Velmurugan K, Deepa R, Ravikumar R et al. Relationship of lipoprotein(a) with intimal medial thickness of the carotid artery in type 2 diabetic patients in south India. Diabet Med 2003;20:455-61.
32. Danesh J, Collins R, Peto R. Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies. Circulation 2000;102:1082-5.
33. Lindsay RS, Funahashi T, Matsuzawa Y et al. Adiponectin Protects Against Development of Type 2 Diabetes in the Pima Indian Population. Lancet 2002;360:57-8.
34. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm LB. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004;291:1730-7.
35. Zoccali C, Mallamaci F, Tripepi G et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 2002;13:134-41.
36. Retnakaran R, Hanley AJG, Raif N, Connelly PW, Sermer M, Zinman B. Hypoadiponectinaemia in south Asian women during pregnancy: evidence of ethnic variation in adiponectin concentration. Diabet Med 2004;21:388-92.
37. Valsamakis G, Chetty R, McTernan PG, Al-Daghri NM, Barnett AH, Kumar S. Fasting serum adiponectin concentration is reduced in Indo-Asian subjects and related to HDL-cholesterol. Diabetes Obes Metab 2003;5:131-5.
38. Abate N, Chandalia M, Snell PG, Grundy SM. Adipose tissue metabolites and insulin resistance in nondiabetic Asian Indian men. J Clin Endocrinol Metab 2002;89:2750-5.
39. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. New Engl J Med 2002;347:1557-65.
40. Forouhi NG, Sattar N, McKeigue PM. Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians. Int J Obes Relat Metab Disord 2001;25: 1327-31.
41. Chandalia M, Cabo-Chan A, Devaraj S, Jialal I, Grundy SM, Abate N. Elevated plasma high-sensitivity C-reactive protein concentrations in Asian Indians living in the United States. J Clin Endocrinol Metab 2003; 88:3773-6.
42. Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ, Schouten EG; MTHFR Studies Collaboration Group. MTHFR 677C-->T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA 2002;288:2023-31.
43. Chambers JC, Obeid OA, Refsum H et al. Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men. Lancet 2000;355:523-7.
44. Wannamethee S, Lowe GD, Whincup PH, Rumley A, Walker M, Lennon L. Physical activity and hemostatic and inflammatory variables in elderly men. Circulation 2002;105:1785-90.
45. Dhawan J, Bray CL. Asian Indians, coronary artery disease and physical exercise. Heart 1997;78:550-4.
46. Lean ME, Han TS, Bush H, Anderson AS, Bradby H, Williams R. Ethnic differences in anthropometric and lifestyle measures related to coronary heart disease risk between south Asian, Italian and general population British women living in the west of Scotland. Int J Obes Relat Metab Disord 2001;25:1800-05.
47. Barnett AH, Grant PJ, Hitman GA et al. on behalf of the Indo-Asian Trial Investigators. Rosiglitazone in type 2 diabetes mellitus: an evaluation in British Indo-Asian patients. Diabet Med 2003;20:387-93.
48. Ammari F, Davies M, Koppiker N, Gregory R, Burden AC. The effect of gliclazide on plasma insulin, intact and 32/33 split proinsulin in south Asian subjects with type 2 diabetes mellitus. Diabet Med 1999;16:142-6.
49. The DECODA study group on behalf of the International Diabetes Epidemiology Group. Cardiovascular risk profile assessment in glucose-intolerant Asian individuals - an evaluation of the World Health Organization two-step strategy: the DECODA study (Diabetes Epidemiology: Collaborative Analysis of Diagnostic Criteria in Asia). Diabet Med 2002;19:549-57.
50. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
51. Pais P, Pogue J, Gerstein H et al. Risk factors for acute myocardial infarction in Indians: a case-control study. Lancet 1996;348:358-63.
52. McKeigue PM, Marmot MG, Adelstein AM et al. Diet and risk factors for coronary heart disease in Asians in northwest London. Lancet 1985;2: 1086-90.
53. Gupta R, Gupta VP, Ahluwalia NS. Educational status, coronary heart disease, and coronary risk factor prevalence in a rural population of India. BMJ 1994;309:1332-6.
54. Diabetes in minority ethnic groups in Scotland. A Report by the National Resource Centre for Ethnic Minority health in collaboration with the Scottish Diabetes Group. 2004. Health Scotland, Glasgow.
55. Mukhopadhyay B, Forouhi N, Fisher BM, Kesson C, Sattar N. South Asians have a more rapid deterioration in glycaemic control relative to Europeans: results from follow up in a routine diabetes clinic. Diabet Med (in press).